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Background: Pancreatic cancer is one of the leading causes of cancer mortality. Diet may be associated with pancreatic cancer,
but it is unknown whether specific dietary components contribute to its risk. The potential differential role of dietary antioxidants
warrants further investigation.
Methods: We analysed data from a case–control study of 326 pancreatic cancer cases and 652 controls conducted between
1991 and 2008 in Northern Italy. Subjects’ usual diet was assessed through a validated and reproducible food frequency
questionnaire. Using this information and an Italian food composition database, we calculated three indices of dietary total
antioxidant capacity (TAC): Trolox equivalent antioxidant capacity (TEAC), total radical-trapping antioxidant parameter (TRAP)
and ferric-reducing antioxidant power (FRAP). We estimated the odds ratios (ORs) and 95% confidence intervals (CIs) for
pancreatic cancer using multiple logistic regression models conditioned on study centre, sex and age, and adjusted for major
known pancreatic cancer risk factors.
Results: Significant inverse associations were found for the highest tertile of TAC compared with the lowest tertile for both TEAC
and FRAP. The ORs were 0.61 (95% CI 0.39–0.94, P-value for trend 0.03) and 0.63 (95% CI 0.41–0.99, P-value for trend 0.05),
respectively. Total radical-trapping antioxidant parameter was inversely, but not significantly, associated with pancreatic cancer
risk, with an OR of 0.78 (95% CI 0.49–1.24, P-value for trend 0.27).
Conclusions: Diet high in TAC, as measured by TEAC and FRAP, is inversely associated with pancreatic cancer risk.
Pancreatic cancer is one of the leading causes of cancer mortality
worldwide (Rahib et al, 2014; Ferlay et al, 2015; Malvezzi et al,
2016). Known risk factors include tobacco use (Iodice et al, 2008),
high levels of alcohol consumption (Michaud et al, 2010; Gapstur
et al, 2011; Lucenteforte et al, 2012), obesity (Arslan et al, 2010;
Genkinger et al, 2011), family history (Verna et al, 2010) and
diabetes (Ben et al, 2011; Bosetti et al, 2014). Several analyses have
been performed of individual nutrients and compounds on
pancreatic cancer risk, but the evidence remains uncertain as to
which aspect of diet is related to pancreatic cancer risk (World
Cancer Research Fund/American Institute for Cancer Research,
2012). Heterocyclic amines (Anderson et al, 2002, 2005) have been
suggested as risk factors for pancreatic cancer, while folate (Skinner
et al, 2004; Larsson et al, 2006), b-carotene (Jeurnink et al, 2015),
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a-tocopherol (Stolzenberg-Solomon et al, 2009; Jeurnink et al, 2015),
vitamin C (Bueno de Mesquita et al, 1991; Gong et al, 2010),
selenium (Banim et al, 2013) and flavonoids (Rossi et al, 2012;
Jeurnink et al, 2015) may protect against pancreatic cancer.
Dietary patterns have also been associated with pancreatic
cancer risk and may provide a more relevant dietary measure of
cancer potential than analysis of individual dietary components.
Adherence to dietary and lifestyle recommendations such as the
World Cancer Research Fund/American Institute for Cancer
Research (WCRF/AICR) recommendations to reduce cancer risk
have been associated with decreased overall cancer risk, but have
not been definitively associated with decreased pancreatic cancer
risk (Romaguera et al, 2012; Lucas et al, 2015). Although elevated
consumption of red meat and low consumption of fruit and
vegetables have been positively associated to the risk of pancreatic
cancer (Anderson et al, 2002, 2005; Polesel et al, 2010; World
Cancer Research Fund/American Institute for Cancer Research,
2012; Bosetti et al, 2013; Lucas et al, 2015), the evidence is
inconsistent to draw conclusions. A common theme to these more
comprehensive dietary approaches is that they are high in dietary
antioxidants.
Total antioxidant capacity (TAC) is a marker of dietary antioxidant
potential, and is defined as the moles of oxidants neutralised by 1 l
plasma, food extracts or single molecules (Serafini et al, 2006).
According to WCRF/AICR recommendations, TAC provides a more
comprehensive overview of dietary patterns as opposed to analysis of
single dietary antioxidants (World Cancer Research Fund/American
Institute for Cancer Research, 2012). We hypothesised that dietary
TAC would be inversely associated with pancreatic cancer risk in a
case–control study of pancreatic cancer subjects.
MATERIALS AND METHODS
We analysed data from a case–control study of pancreatic cancer
conducted between 1991 and 2008 in Milan and Pordenone, Italy
(Polesel et al, 2010). Cases were 326 subjects (174 men, 152 women,
median age 63 years, range 34–80 years) with incident pancreatic
cancer admitted to major general hospitals in the study centres.
Controls were 652 subjects (348 men, 304 women, frequency-
matched according to age (±5 years), sex and study centre) with a 2:1
ratio. Controls were admitted to the same teaching or general
hospitals as cases for a variety of acute non-neoplastic diagnoses,
including acute surgical conditions (28%), traumatic orthopaedic
conditions (31%), other orthopaedic conditions (31%) and other
miscellaneous conditions (10%). Over 95% of cases and controls who
were approached agreed to participate. All enrolled subjects signed an
informed consent, according to the recommendations of the Board of
Ethics of each participating centre.
All subjects were interviewed by centrally trained interviewers
using a structured questionnaire that included socio-demographic
factors, lifestyle habits (including history of tobacco use, alcohol
use and physical activity), anthropometric measures (e.g., self-
reported height and weight at different ages), personal medical
history of selected diseases (e.g., diabetes) and history of cancer in
first-degree relatives. Subject’s usual diet two years before cancer
diagnosis (cases) or hospital admission (controls) was assessed
though a validated (Decarli et al, 1996) and reproducible
(Franceschi et al, 1993) food frequency questionnaire (FFQ),
which included data on 83 foods and beverages grouped into seven
sections: (1) bread and cereal dishes; (2) meat, fish and other main
dishes; (3) potatoes and vegetables; (4) fruit; (5) sweets, desserts
and soft drinks; (6) dairy and hot beverages (including tea and
coffee); and (7) alcohol consumption. Subjects indicated average
weekly consumption of each item; those with intermediate use
were assigned frequency of 0.5.
The most commonly used measures of TAC are the Trolox
equivalent antioxidant capacity (TEAC), the total radical-trapping
antioxidant parameter (TRAP) and the ferric-reducing antioxidant
power (FRAP) (Prior et al, 2005). TEAC and FRAP are based on
single electron transfer mechanism and measure the ability of
antioxidants to scavenge to the stable radical cation ABTSþ (2,20-
azinobis(3-ethylbenzothiazoline-6-sulfonic acid)) and to reduce
Fe3þ (ferric ion) to Fe2þ (ferrous ion). Total radical-trapping
antioxidant parameter measures the chain-breaking potential to
reduce peroxyl radicals generated by AAPH ((2,2-azobis(2-
amidinopropane) dihydrochloride)) or ABAP (2,20azobis(2-amidi-
nopropane) dihydrochloride) and represents a measurement of the
hydrogen atom transfer mechanism (Re et al, 1999).
Using the Italian food composition database (Gnagnarella et al,
2004), an ad hoc database was developed to calculate TAC for each
of the three indices (i.e., TEAC, TRAP and FRAP) based on
experimental assessment of the food extracts (Pellegrini et al, 2003,
2006). A total of 64 items contribute to the assessment of TEAC, 57
to TRAP and 59 to FRAP in this study. Coffee was excluded from
the TAC estimate, since the main contributors to in vitro
antioxidant capacity of coffee are the Maillard reaction products
(creating during the coffee roasting of beans) (Delgado-Andrade
and Morales, 2005), whose absorption and antioxidant capacity
in vivo have not been demonstrated (Morales et al, 2012). In
addition, due to their high molecular weight, they may function in
a different manner from other antioxidants. Intake of total energy
was computed using an Italian food composition database
(Gnagnarella et al, 2004).
Energy-adjusted TEAC, TRAP and FRAP were categorised into
tertiles based on the control distribution. We estimated the
corresponding odds ratios (ORs) and 95% confidence intervals
(CIs) for pancreatic cancer using conditional multiple logistic
regression models, controlled for study centre (Milan, Pordenone),
sex, age (5-year intervals) and adjusted for year of interview
(continuous), years of education (o7, 7–11, X12, categorically),
body mass index (BMI) (o25, 25–30,X30 kgm 2, categorically),
tobacco use (never smoker, ex-smoker, current smoker o15 and
X15 cigarettes per day, categorically), alcohol intake (non-
drinkers, o28 g of ethanol per day, 428 g of ethanol per day,
categorically) and diabetes (yes, no). Energy intake was adjusted for
using the residual model (Willett and Stampfer, 1986). We also
fitted models in strata of sex, age, BMI, tobacco smoking, alcohol
use and history of diabetes, and assessed the heterogeneity of the
risk estimates across strata using the Wald w2-test.
RESULTS
The distribution of 326 pancreatic cancer cases and 652 controls
according to sex, age and other selected characteristics is shown in
Table 1. No significant differences were noted for education, BMI and
alcohol consumption. Compared with controls, cases were more often
smokers and more frequently had a history of diabetes. When
analysing the distribution of these characteristics among tertiles of the
three energy-adjusted TAC indices, subjects in the higher tertiles were
more frequently men, current smokers and alcohol drinkers; more-
over, they had a higher intake of fruit and vegetables and a lower
consumption of cereals (Supplementary Table 1).
Table 2 provides the distribution of pancreatic cancer cases and
controls with the corresponding ORs and 95% CIs by tertiles of
energy-adjusted dietary TAC indices. Significant inverse associa-
tions were noted between TEAC and FRAP and pancreatic cancer
risk; the OR for the highest tertile of TEAC compared with the
lowest tertile was 0.61 (95% CI 0.39–0.94, P-value for trend 0.03),
and the OR for FRAP was 0.63 (95% CI 0.41–0.99, P-value for
trend 0.05). TRAP was inversely but not significantly associated
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with pancreatic cancer risk, with an OR of 0.78 (95% CI 0.49–1.24,
P-value for trend 0.27).
Table 3 gives the ORs for pancreatic cancer according to tertiles
of TEAC and FRAP by strata of selected covariates. The association
between TEAC and FRAP and pancreatic cancer risk was
apparently stronger (although not significantly) in subjects with
a history of tobacco use. No differences were noted across strata of
sex, age, BMI, alcohol use and history of diabetes. Given the low
number of diabetic subjects, we also computed continuous OR for
an increment equal to 1 s.d. For TEAC, the continuous OR was
0.81 (95% CI, 0.41–1.62) among diabetic subjects and 0.91 (95%
CI, 0.75–1.10) among non-diabetic subjects. The continuous OR
for FRAP was 0.69 (95% CI, 0.36–1.35) among diabetic subjects
and 0.93 (95% CI, 0.77–1.12) among non-diabetic subjects.
DISCUSSION
The association between antioxidants and pancreatic cancer risk is
complex, with overall mixed results. Dietary intake of single
antioxidants such as vitamin C (Bueno de Mesquita et al, 1991;
Gong et al, 2010), a-tocopherol (Stolzenberg-Solomon et al, 2009;
Bravi et al, 2011; Jeurnink et al, 2015), b-carotene (Olsen et al,
1991; Jeurnink et al, 2015), flavonoids (Nothlings et al, 2008; Rossi
et al, 2012; Arem et al, 2013) and selenium (Banim et al, 2013) has
been associated with decreased risk of pancreatic cancer. However,
the intake of individual antioxidant supplements has failed to
demonstrate a protective effect in pancreatic cancer (Rautalahti
et al, 1999; Heinen et al, 2012; Han et al, 2013). We hypothesised
that antioxidants may have an important role in pancreatic cancer
risk, but that there may be interactions between antioxidant
supplements and other dietary components that abrogate a
beneficial effect.
Plant-based diets, rich in dietary antioxidants, have been
associated with decreased pancreatic cancer risk (Anderson et al,
2005; Polesel et al, 2010; Bosetti et al, 2013). Also the
Mediterranean diet has been associated with decreased pancreatic
cancer risk and is rich in antioxidants (Bosetti et al, 2013). Thus,
these data are in line with our findings suggesting that a diet high
in TAC is associated with decreased pancreatic cancer risk.
Antioxidants are thought to reduce oxidative DNA damage and
subsequent genetic mutations, and therefore may provide a
protective effect against cancer (Foksinski et al, 2007). Tobacco
smoke promotes cancer by a variety of different mechanisms,
including genetic mutations in tumour suppressors and oncogenes,
gene promoter hypermethylation and protein kinase activation
((U.S. Department of Health and Human Services, 2010) and
therefore may modify the effect of antioxidants on cancer risk
(Woodson et al, 1999; Wu et al, 2015). Our data indicating that
the association between dietary antioxidant and pancreatic cancer
may be stronger in subjects with a history of tobacco exposure
could suggest that those exposed to increased oxidative stress may
benefit the most from a diet high in antioxidants (Lettieri-Barbato
et al, 2013). Further studies are warranted, as our results did not
reach statistical significance.
All three indices were inversely related to pancreatic cancer, but
the association was not significant for TRAP. Apart from the play
of chance, this might be because of the fact that TRAP is more
strongly influenced by the consumption of alcoholic beverages as
compared with FRAP and TEAC (Praud et al, 2015), and alcohol
use is positively related to pancreatic cancer risk (Gapstur et al,
2011; Lucenteforte et al, 2012). In addition, the TRAP assay has a
high specificity for antioxidant behaviour, such as peroxyl radical
scavenging activity, compared with FRAP and TEAC, respectively
addressing iron reduction and scavenging of the not physiological
ABTSþ . Trapping antioxidant parameter provides more direct
evidence of the canonical antioxidant activity, but at the same time
since it is more specific, the test requires evidence of a redox
condition (Serafini et al, 2006).
Limitations of the study include the hospital-based case–control
design. Pancreatic cancer subjects and hospitalised controls may
differ from those in the general population. We attempted to
minimise selection bias by selecting controls that were admitted for
reasons such as trauma and acute surgical conditions, and
excluding those with a cancer diagnosis. We additionally attempted
to limit bias by having the same trained interviewers administering
the questionnaire to both cases and controls under similar
conditions. Responses to dietary questionnaires may introduce
some bias for those with a recent diagnosis of cancer. To minimise
this, we asked about diet in the 2 years before cancer diagnosis. We
also excluded controls with long-term diagnoses that required
dietary modifications. At the time of study enrolment, limited data
was available on pancreatic cancer risk factors; therefore, recall bias
should be minimal. Data were not available on dietary supple-
ments, which may be contributors to TAC; however, their use was
infrequent in this study population during the study period (Sette
et al, 2013). Our dietary TAC assay measures in vitro antioxidant
activity which may not fully represent in vivo activity, due to still
Table 1. Distribution of 326 cases of pancreatic cancer and
652 controls according to study centre, sex, age and other
selected variables. Italy, 1991–2008
Cases Controls
Characteristics No. % No. %
Study centre
Milan 151 46.3 302 46.3
Pordenone 175 53.7 350 53.7
Sex
Men 174 53.4 348 53.4
Women 152 46.6 304 46.6
Age (years)
o50 32 9.8 64 9.8
X50–o55 31 9.5 62 9.5
X55–o60 58 17.8 116 17.8
X50–o65 65 19.9 130 19.9
X65–o70 57 17.5 114 17.5
X70 83 25.5 166 25.5
Education (years)a
o7 166 51.2 350 53.9
7–o12 86 26.5 192 29.5
X12 72 22.2 108 16.6
Body mass index (kgm2)a
o25 139 42.9 264 40.7
25–o30 135 41.7 296 45.6
X30 50 15.4 89 13.7
Smoking statusa
Never smokers 137 42.4 328 50.5
Ex-smokers 86 26.6 189 29.1
Current smokers
o15 Cigarettes per day 36 11.2 60 9.2
X15 Cigarettes per day 64 19.8 72 11.1
Alcohol drinkers (tertiles)b
I 96 29.5 218 33.4
II 108 33.1 218 33.4
II 122 37.4 216 33.2
History of diabetes
No 279 85.6 615 94.3
Yes 47 14.4 37 5.7
aThe sum does not add up to the total because of some missing values.
bOn the basis of the control distribution. Tertiles of alcohol were calculated in grams of
ethanol per day.
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Table 2. Distribution of 326 pancreatic cancer case and 652 control patients and corresponding ORsa and 95% CIs by tertiles of
three energy-adjusted TAC indices. Italy, 1991–2008
Tertilesb
Mean (SD)a I II III P for trend
TEAC 4.39 (2.30)
Cases:controls 119:217 105:218 102:217
Upper cutoff points (mmol Trolox per day)c 3.67 4.77 —
OR (95% CI)d 1e 0.82 (0.56–1.20) 0.61 (0.39–0.94) 0.028
TRAP 4.51 (2.81)
Cases:controls 114:217 105:218 107:217
Upper cutoff points (mmol Trolox per day)c 3.47 5.00 —
OR (95% CI)d 1e 0.84 (0.57–1.24) 0.78 (0.49–1.24) 0.27
FRAP 11.23 (5.98)
Cases:controls 117:218 111:217 98:217
Upper cutoff points (mmol Fe2þ per day)c 9.17 12.29 —
OR (95% CI)d 1e 0.88 (0.61–1.29) 0.63 (0.41–0.99) 0.048
Abbreviations: CI¼ confidence interval; OR¼odds ratio; FRAP¼ ferric-reducing antioxidant power; SC¼ standard deviation; TAC¼ total antioxidant capacity; TEAC¼Trolox equivalent
antioxidant capacity; TRAP¼ trapping antioxidant parameter.
aMean and s.d. among controls.
bOn the basis of the control distribution.
cComputed as the sum of the upper cutoff points of energy-adjusted TAC tertiles plus the means of TAC.
dEstimates from logistic regression models, conditioned on study centre, sex and age, and adjusted for year of interview, education, body mass index, tobacco smoking, alcohol intake,
diabetes and energy intake according to the residual method.
eReference category.
Table 3. ORs of pancreatic cancer and 95% CIs by tertiles of TEAC and FRAP by selected covariates. Italy, 1991–2008
OR, 95% CIa
TEAC, tertiles FRAP, tertiles
Cases:controls II III II III
Sex
Men 174:338 1.00 (0.57–1.78) 0.71 (0.39–1.29) 1.04 (0.59–1.83) 0.68 (0.38–1.23)
Women 152:304 0.70 (0.41–1.19) 0.55 (0.28–1.10) 0.73 (0.43–1.24) 0.61 (0.30–1.26)
P valueb 0.71 0.64
Age (years)
o65 186:372 0.85 (0.51–1.42) 0.58 (0.32–1.08) 0.91 (0.55–1.51) 0.62 (0.34–1.15)
X65 140:280 0.84 (0.47–1.51) 0.75 (0.39–1.45) 0.90 (0.50–1.61) 0.75 (0.39–1.47)
P valueb 0.48 0.49
BMI (kgm2)
o25 139:264 0.93 (0.50–1.71) 0.88 (0.42–1.82) 1.06 (0.59–1.93) 0.78 (0.38–1.63)
X25 185:385 0.94 (0.55–1.60) 0.61 (0.34–1.10) 0.93 (0.54–1.59) 0.67 (0.37–1.21)
P valueb 0.98 0.70
Smoking statusc
Never 137:330 0.68 (0.39–1.21) 0.72 (0.36–1.44) 0.88 (0.50–1.57) 0.84 (0.42–1.57)
Ever 188:322 0.96 (0.55–1.68) 0.49 (0.27–0.91) 0.83 (0.48–1.43) 0.46 (0.25–0.86)
P valueb 0.30 0.36
Alcohol (tertiles)d
I 96:218 0.70 (0.36–1.34) 0.34 (0.11–1.07) 0.72 (0.38–1.37) 0.54 (0.17–1.70)
II 108:218 1.02 (0.54–1.93) 0.70 (0.32–1.52) 1.14 (0.60–2.16) 0.70 (0.32–1.54)
III 122:216 1.00 (0.38–2.64) 0.65 (0.28–1.55) 0.93 (0.35–2.44) 0.63 (0.27–1.49)
P valueb 0.76 0.96
History of diabetes
No 269:615 0.87 (0.58–1.30) 0.70 (0.44–1.12) 0.90 (0.60–1.35) 0.74 (0.47–1.19)
Yes 57:37 0.60 (0.15–2.43) 0.33 (0.05–2.35) 0.74 (0.16–3.40) 0.14 (0.02–1.19)
P valueb 0.67 0.44
Abbreviations: BMI¼body mass index; CI¼ confidence interval; FRAP¼ ferric-reducing antioxidant power; OR¼odds ratio; TEAC¼Trolox equivalent antioxidant capacity.
aEstimates from logistic regression models, conditioned on study centre, sex and age, and adjusted for year of interview, education, body mass index, tobacco smoking, alcohol intake,
diabetes and energy intake according to the residual method. Reference category is the first tertile.
bP for heterogeneity.
cThe sum does not add up to the total because of some missing values.
dOn the basis of the control distribution.
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unclear association between dietary and endogenous antioxidant
and to the low bioavailability of flavonoids (Manach et al, 2004;
Serafini et al, 2011). The FFQ was reproducible (Franceschi et al,
1993) and valid (Decarli et al, 1996), and the reproducibility of
FFQ data provided by hospital controls was satisfactory (D’Avanzo
et al, 1997). Strengths of the study include the ability to control for
other known pancreatic cancer risk factors, and near-complete data
collection for both cases and controls.
Thus, we found that a diet high in antioxidant potential, as
measured by dietary TEAC and FRAP, is associated with a
decreased risk of pancreatic cancer. The association may be
stronger in those with a history of tobacco exposure, although this
was not statistically heterogeneous. Our findings provide evidence
that a diet high in dietary antioxidants may be protective against
pancreatic cancer.
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